Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.
作者信息
Spellberg Brad, Nielsen Travis B, Gilbert David N, Shorr Andrew F, Brass Eric P
机构信息
Los Angeles County and University of Southern California Medical Center, Los Angeles, California (B.S.).
Stritch School of Medicine and Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, Illinois (T.B.N.).
出版信息
Ann Intern Med. 2019 Oct 15;171(8):580-582. doi: 10.7326/M19-1893. Epub 2019 Oct 8.
Abstract
摘要
相似文献
1
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.确保所需抗生素的可持续性：以飞镖靶为目标。
Ann Intern Med. 2019 Oct 15;171(8):580-582. doi: 10.7326/M19-1893. Epub 2019 Oct 8.
2
Antibiotic development - economic, regulatory and societal challenges.抗生素研发——经济、监管及社会挑战
Nat Rev Microbiol. 2020 May;18(5):267-274. doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.
3
Antimicrobial drug discovery: lessons of history and future strategies.抗菌药物发现：历史教训与未来策略
Expert Opin Drug Discov. 2018 Nov;13(11):983-985. doi: 10.1080/17460441.2018.1515910. Epub 2018 Aug 29.
4
Priority pathogens and the antibiotic pipeline: an update.重点病原体与抗生素研发进展：最新情况
Bull World Health Organ. 2020 Mar 1;98(3):151. doi: 10.2471/BLT.20.251751.
5
Together towards a common goal: REVIVE, a community of antimicrobial researchers brought together by the Global Antibiotic Research & Development Partnership (GARDP).携手迈向共同目标：REVIVE，一个由全球抗菌药物研究与开发伙伴关系（GARDP）召集的抗菌药物研究人员共同体。
J Antimicrob Chemother. 2019 Jul 1;74(7):1769-1770. doi: 10.1093/jac/dkz077.
6
Steps to address anti-microbial drug resistance in today's drug discovery.当今药物研发中应对抗菌药物耐药性的步骤。
Expert Opin Drug Discov. 2019 Feb;14(2):91-94. doi: 10.1080/17460441.2019.1550481. Epub 2018 Nov 22.
7
Tackle antimicrobial resistance with a pandemic-style mobilization.
Nature. 2022 Dec;612(7940):S32. doi: 10.1038/d41586-022-04212-3.
8
Policy: An intergovernmental panel on antimicrobial resistance.政策：一个关于抗微生物药物耐药性的政府间小组。
Nature. 2014 May 29;509(7502):555-7. doi: 10.1038/509555a.
9
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.美国学术界药物发现与开发的现状：工业界与学术界合作对药物发现与开发的影响。
Clin Transl Sci. 2018 Nov;11(6):597-606. doi: 10.1111/cts.12577. Epub 2018 Jul 30.
10
Europe to boost development of new antimicrobial drugs.欧洲将推动新型抗菌药物的研发。
Lancet. 2012 Jun 16;379(9833):2229-30. doi: 10.1016/s0140-6736(12)60964-7.
引用本文的文献
1
Sustainable solutions to the continuous threat of antimicrobial resistance.应对抗菌素耐药性持续威胁的可持续解决方案。
Health Aff Sch. 2025 Jan 24;3(2):qxaf012. doi: 10.1093/haschl/qxaf012. eCollection 2025 Feb.
2
A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution.非营利性药物研发模式是解决抗生素耐药性（AMR）问题的一部分。
Clin Infect Dis. 2022 May 30;74(10):1866-1871. doi: 10.1093/cid/ciab887.
3
Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection.单克隆抗体需要免疫调节以对抗鲍曼不动杆菌感染的疗效。
J Infect Dis. 2021 Dec 15;224(12):2133-2147. doi: 10.1093/infdis/jiab265.
4
Alignment With Market Forces: The "Re-Whithering" of Infectious Diseases.与市场力量接轨：传染病的“再度凋零”
Open Forum Infect Dis. 2020 Jun 20;7(8):ofaa245. doi: 10.1093/ofid/ofaa245. eCollection 2020 Aug.
本文引用的文献
1
Adaptive platform trials: definition, design, conduct and reporting considerations.适应性平台试验：定义、设计、实施和报告考虑因素。
Nat Rev Drug Discov. 2019 Oct;18(10):797-807. doi: 10.1038/s41573-019-0034-3. Epub 2019 Aug 28.
2
Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future?抗生素的可持续发现与开发——非营利性方法会是未来的方向吗？
N Engl J Med. 2019 Aug 8;381(6):503-505. doi: 10.1056/NEJMp1905589. Epub 2019 Jun 19.
3
New Societal Approaches to Empowering Antibiotic Stewardship.增强抗生素管理的新社会方法
JAMA. 2016;315(12):1229-30. doi: 10.1001/jama.2016.1346.
4
The future of antibiotics and resistance.抗生素与耐药性的未来。
N Engl J Med. 2013 Jan 24;368(4):299-302. doi: 10.1056/NEJMp1215093.
5
White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.白皮书：关于治疗耐药细菌病原体引起的感染的抗菌药物优越性和生物体特异性临床试验实施的建议。
Clin Infect Dis. 2012 Oct;55(8):1031-46. doi: 10.1093/cid/cis688. Epub 2012 Aug 13.
6
Medicine's responsibility in the propagation of poor protoplasm.医学在劣质原生质繁衍方面的责任。
N Engl J Med. 1948 May 27;238(22):755-8. doi: 10.1056/NEJM194805272382201.
7
Round table: are new antibiotics needed?
Antimicrob Agents Chemother (Bethesda). 1965;5:1107-14.
Zotero 插件